We found that overexpression of LSD2 in breast cancer cells consistently enhances MDA-MB-231 cell growth in vitro as well as in tumor xenografts in mice, whereas depletion of LSD2 by siRNA hinders the growth of multiple breast cancer cell lines. Here, KDM1B is linked to breast carcinoma.